These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11966740)

  • 1. A novel bioassay for human somatogenic activity in serum samples supports the clinical reliability of immunoassays.
    Rowland JE; Marshall NJ; Leung KC; Ho KK; Cotterill AM; Rowlinson SW; Waters MJ
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):475-85. PubMed ID: 11966740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders.
    Bozzola M; Zecca M; Locatelli F; Radetti G; Pagani S; Autelli M; Tatò L; Chatelain P
    J Endocrinol Invest; 1998 Dec; 21(11):765-70. PubMed ID: 9972677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel specific bioassay for serum human growth hormone.
    Ishikawa M; Nimura A; Horikawa R; Katsumata N; Arisaka O; Wada M; Honjo M; Tanaka T
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4274-9. PubMed ID: 11095467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The measurement of growth hormone bioactivity in patient serum using an eluted stain assay.
    Dattani MT; Hindmarsh PC; Pringle PJ; Brook CG; Marshall NJ
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2675-83. PubMed ID: 7545696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a bioassay system for human growth hormone determination with close correlation to immunoassay.
    Maimaiti M; Tanahashi Y; Mohri Z; Fujieda K
    J Clin Lab Anal; 2012 Sep; 26(5):328-35. PubMed ID: 23001977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced human growth hormone (hGH) bioactivity without a defect of the GH-1 gene in three patients with rhGH responsive growth failure.
    Binder G; Benz MR; Elmlinger M; Pflaum CD; Strasburger CJ; Ranke MB
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):89-95. PubMed ID: 10468970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of growth hormone (GH) bioactivity by a recombinant human GH-binding protein.
    Lim L; Spencer SA; McKay P; Waters MJ
    Endocrinology; 1990 Sep; 127(3):1287-91. PubMed ID: 2387255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of an eluted stain bioassay (ESTA) for human growth hormone.
    Ealey PA; Yateman ME; Sandhu R; Dattani MT; Hassan MK; Holt SJ; Marshall NJ
    Growth Regul; 1995 Mar; 5(1):36-44. PubMed ID: 7538369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into the lability of the bioactivity of human growth hormone using the ESTA bioassay.
    Dattani MT; Ealey PA; Pringle PJ; Hindmarsh PC; Brook CG; Marshall NJ
    Horm Res; 1996; 46(2):64-73. PubMed ID: 8871184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human growth hormone-binding protein fails to enhance the in vivo bioactivity of human growth hormone in normal rats.
    Tzanela M; Wagner C; Tannenbaum GS
    Endocrinology; 1997 Dec; 138(12):5316-24. PubMed ID: 9389516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivity of human growth hormone in serum: validation of an in vitro bioassay.
    Foster CM; Borondy M; Padmanabhan V; Schwartz J; Kletter GB; Hopwood NJ; Beitins IZ
    Endocrinology; 1993 May; 132(5):2073-82. PubMed ID: 8477657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-directed mutagenesis of recombinant bovine placental lactogen at lysine-73 leads to selective attenuation of its somatogenic activity.
    Helman D; Staten NR; Byatt J; Grosclaude J; McKinnie RE; Djiane J; Gertler A
    Endocrinology; 1997 Oct; 138(10):4069-80. PubMed ID: 9322914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of the GH/IGF-axis components: lessons from human studies.
    Frystyk J
    Domest Anim Endocrinol; 2012 Aug; 43(2):186-97. PubMed ID: 22153974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is BaF3 bioassay useful to identify patients with bioinactive growth hormone?
    Pagani S; Chaler EA; Meazza C; Maceiras M; Gonzalez ME; Rivarola MA; Cantoni F; Travaglino P; Della Croce L; Laarej K; Bozzola M; Belgorosky A
    J Pediatr Endocrinol Metab; 2010 Aug; 23(8):783-8. PubMed ID: 21073121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement.
    Strasburger CJ; Wu Z; Pflaum CD; Dressendörfer RA
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2613-20. PubMed ID: 8675586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans.
    Solomon G; Reicher S; Gussakovsky EE; Jomain JB; Gertler A
    Growth Horm IGF Res; 2006; 16(5-6):297-307. PubMed ID: 17010651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of growth hormone bioactivity by recombinant human growth hormone-binding protein in the eluted stain assay system.
    Dattani MT; Hindmarsh PC; Brook CG; Robinson IC; Marshall NJ
    J Endocrinol; 1994 Mar; 140(3):445-53. PubMed ID: 8182373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between the human serum growth hormone-binding protein and the water-soluble growth hormone-binding site released from IM-9 lymphocytes.
    Massa G; Ilondo M; Vanderschueren-Lodeweyckx M
    Acta Endocrinol (Copenh); 1993 Dec; 129(6):559-64. PubMed ID: 8109191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells.
    Hansen BS; Hjorth S; Welinder BS; Skriver L; De Meyts P
    Endocrinology; 1993 Dec; 133(6):2809-17. PubMed ID: 8243308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems.
    Rowlinson SW; Waters MJ; Lewis UJ; Barnard R
    Endocrinology; 1996 Jan; 137(1):90-5. PubMed ID: 8536647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.